BIOMAT Database Logo BIOMAT Database Logo

[Glomerulonephritis and anticoagulants: therapy with dipyridamole in lupoid glomerulonephritis]. 1972

M Barlattani, and G Guglielmi, and A Mammarella

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

M Barlattani, and G Guglielmi, and A Mammarella
Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
July 1973, The Medical journal of Australia,
M Barlattani, and G Guglielmi, and A Mammarella
[Treatment with anticoagulants in glomerulonephritis (author's transl)].
November 1979, Medizinische Klinik,
M Barlattani, and G Guglielmi, and A Mammarella
Rapidly progressive glomerulonephritis treated with anticoagulants.
January 1972, Archives of internal medicine,
M Barlattani, and G Guglielmi, and A Mammarella
[Treatment of chronic glomerulonephritis with heparin and anticoagulants].
October 1974, Nihon rinsho. Japanese journal of clinical medicine,
M Barlattani, and G Guglielmi, and A Mammarella
Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
December 1983, The American journal of medicine,
M Barlattani, and G Guglielmi, and A Mammarella
[Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
March 1988, Schweizerische medizinische Wochenschrift,
M Barlattani, and G Guglielmi, and A Mammarella
Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis.
June 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Barlattani, and G Guglielmi, and A Mammarella
[LUPOID NEPHRITIS. DESCRIPTION OF AUTOIMMUNE FORM OF PRIMARY CHRONIC GLOMERULONEPHRITIS].
August 1965, Deutsche medizinische Wochenschrift (1946),
M Barlattani, and G Guglielmi, and A Mammarella
[Etiology and therapy of "lupoid hepatitis"].
February 1968, Munchener medizinische Wochenschrift (1950),
M Barlattani, and G Guglielmi, and A Mammarella
Dipyridamole for proteinuria suppression. Use in a patient with proliferative glomerulonephritis.
July 1974, JAMA,
Copied contents to your clipboard!